Israel - English - Ministry of Health

lapidot medical import and marketing ltd - sodium chloride - solution for injection - sodium chloride 0.9 g / 100 ml - sodium chloride - sodium chloride - short - term intravascular volume substitution. hypotonic dehydration or isotonic dehydration.vehicle solution for supplementary medication.fluid and electrolyte replacement, hypochloremic alkalosis and chloride losses.externally for wound irrigation and moistening of wound tamponade dressings.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: water for injections - sodium chloride injection bp 0.9% can be used as the vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: water for injections - sodium chloride injection bp 0.9% can be used as the vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - sodium chloride, quantity: 9 mg/ml - injection, solution - excipient ingredients: water for injections - sodium chloride injection bp 0.9% can be used as the vehicle for many parenteral drugs and as an electrolyte replenisher for maintenance or replacement of deficits of extracellular fluid. it can also be used as a sterile irrigation medium.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - sodium chloride, quantity: 90 mg - injection, solution - excipient ingredients: water for injections - sodium chloride injection solution is used for the restoration and maintenance of salt and extracellular fluid levels or as a vehicle for the administration of parenteral drugs.

United States - English - NLM (National Library of Medicine)

american regent, inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance. gastrointesti

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance.

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - l-leucine; l-phenylalanine; l-methionine; l-lysine; l-isoleucine; l-valine; l-histidine; l-threonine; l-tryptophan; l-alanine; l-arginine; glycine; l-proline; l-serine; l-tyrosine; sodium acetate trihydrate ; dibasic potassium phosphate ; sodium chloride; magnesium chloride hexahydrate; glucose; calcium chloride dihydrate - solution for infusion - solutions for parenteral nutrition; amino acids

Malta - English - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - glucose anhydrous, sodium chloride, sodium acetate, trihydrate, potassium chloride, magnesium chloride, hexahydrate - solution for infusion - glucose anhydrous 50 g sodium chloride 1 g sodium acetate trihydrate 3.13 g potassium chloride 1.5 g magnesium chloride hexahydrate 0.30 g - blood substitutes and perfusion solutions

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

inqaba biotec east africa limited, tanzania - laboratory reagent -